Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy … S Zuklys, G Balciunaite, A Agarwal, E Fasler-Kan, E Palmer, ... The Journal of Immunology 165 (4), 1976-1983, 2000 | 331 | 2000 |
Circulating microparticles: square the circle NS Barteneva, E Fasler-Kan, M Bernimoulin, JNH Stern, ED Ponomarev, ... BMC cell biology 14, 1-21, 2013 | 310 | 2013 |
Imaging flow cytometry: coping with heterogeneity in biological systems NS Barteneva, E Fasler-Kan, IA Vorobjev Journal of Histochemistry & Cytochemistry 60 (10), 723-733, 2012 | 267 | 2012 |
The Tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid leukemia cells IG Silva, IM Yasinska, SS Sakhnevych, W Fiedler, J Wellbrock, M Bardelli, ... EBioMedicine 22, 44-57, 2017 | 224 | 2017 |
The Tim-3-Galectin-9 pathway and its regulatory mechanisms in human breast cancer IM Yasinska, SS Sakhnevych, L Pavlova, A Teo Hansen Selnø, ... Frontiers in immunology 10, 1594, 2019 | 170 | 2019 |
Defective Jak‐STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon‐α A Pansky, P Hildebrand, E Fasler‐Kan, L Baselgia, S Ketterer, ... International journal of cancer 85 (5), 720-725, 2000 | 142 | 2000 |
Interferon‐α activates signal transducers and activators of transcription 5 and 6 in Daudi cells E Fasler‐Kan, A Pansky, M Wiederkehr, M Battegay, MH Heim European journal of biochemistry 254 (3), 514-519, 1998 | 95 | 1998 |
Ligand-receptor interactions of galectin-9 and VISTA suppress human T lymphocyte cytotoxic activity IM Yasinska, NH Meyer, S Schlichtner, R Hussain, G Siligardi, ... Frontiers in immunology 11, 580557, 2020 | 78 | 2020 |
The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells I Gonçalves Silva, L Rüegg, BF Gibbs, M Bardelli, A Fruehwirth, L Varani, ... Oncoimmunology 5 (7), e1195535, 2016 | 76 | 2016 |
Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease I Mecklenburg, D Reznik, E Fasler-Kan, J Drewe, C Beglinger, P Hruz, ... Journal of Crohn's and Colitis 8 (11), 1392-1397, 2014 | 69 | 2014 |
The immune receptor Tim-3 mediates activation of PI3 kinase/mTOR and HIF-1 pathways in human myeloid leukaemia cells A Prokhorov, BF Gibbs, M Bardelli, L Rüegg, E Fasler-Kan, L Varani, ... The international journal of biochemistry & cell biology 59, 11-20, 2015 | 67 | 2015 |
Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma A Pansky, A DE WEERTH, E Fasler-Kan, JL Boulay, M Schulz, S Ketterer, ... Journal of the American Society of Nephrology 11 (8), 1409-1418, 2000 | 64 | 2000 |
Dimethyl fumarate, a small molecule drug for psoriasis, inhibits Nuclear Factor-κB and reduces myocardial infarct size in rats S Meili-Butz, T Niermann, E Fasler-Kan, V Barbosa, N Butz, D John, ... European journal of pharmacology 586 (1-3), 251-258, 2008 | 63 | 2008 |
Extracellular vesicles in gastrointestinal cancer in conjunction with microbiota: On the border of Kingdoms NS Barteneva, Y Baiken, E Fasler-Kan, K Alibek, S Wang, N Maltsev, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1868 (2), 372-393, 2017 | 52 | 2017 |
High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression IM Yasinska, I Gonçalves Silva, SS Sakhnevych, L Ruegg, R Hussain, ... Oncoimmunology 7 (6), e1438109, 2018 | 46 | 2018 |
Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3 E Fasler-Kan, C Suenderhauf, N Barteneva, B Poller, D Gygax, J Huwyler Brain research 1354, 15-22, 2010 | 40 | 2010 |
Cell sorting in cancer research—diminishing degree of cell heterogeneity NS Barteneva, K Ketman, E Fasler-Kan, D Potashnikova, IA Vorobjev Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1836 (1), 105-122, 2013 | 38 | 2013 |
Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 … ATH Selnø, S Schlichtner, IM Yasinska, SS Sakhnevych, W Fiedler, ... Aging (Albany NY) 12 (23), 23478, 2020 | 35 | 2020 |
Activated STAT3 in choroidal neovascular membranes of patients with age-related macular degeneration E Fasler-Kan, K Wunderlich, P Hildebrand, J Flammer, P Meyer Ophthalmologica 219 (4), 214-221, 2005 | 34 | 2005 |
On prilled nanotubes-in-microgel oral systems for protein delivery JK de Kruif, G Ledergerber, C Garofalo, E Fasler-Kan, M Kuentz European Journal of Pharmaceutics and Biopharmaceutics 101, 90-102, 2016 | 32 | 2016 |